European drug market

EU Drug Market: Drivers and facilitators

Report

30 May 2024

EU Drug Market: Drivers and facilitators provides an overview of the key factors influencing the operation of the markets for illicit drugs in the European Union. It considers the changes and developments happening in the wider environment...

Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons

Book

Source: https://www.emcdda.europa.eu/system/files/publications/13745/TD0321143ENN_002.pdf Summary Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce...

Webinar: EU Drug Market Report 2019

10 December 2019

Webinar

Description:

The aim of the webinar is to enable participants to understand the concept of the illicit drug market within the broader context of changing patterns of drug use, cultural and social factors and links to wider criminality; to describe to participants in detail the markets for the main drug types and the key points, and to talk about the opportunities for improvement of operational practices by using strategic analysis.

EU Drug Markets Report 2019

Book

The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis presented in the report examines topics such as the links between drugs and other...

European Drug Report (EDR) 2019: Trends and Developments

Book

6 June 2019

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has published the latest European Drug Report, which provides an analysis of the latest data on the drug trends across the European Union, Norway and Turkey. The aim of...

European Drugs Summer School

24 June 2019

Lisbon

Portugal

Key Points from EMCDDA’s 2016 European Drug Report

Book

9 January 2017

As we welcome in the New Year it seems an ideal time to take stock and present the key points from the 2016 European Drug Report (EDR), the European Monitoring Centre for Drug and Addiction’s (EMCDDA) annual review of the European drug...